11th May 2017 16:00
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
11 May 2017
Notification of Major Interest in Mediclinic International plc shares
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | Mediclinic International plc
| |||||||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||||||||||||||||
An acquisition or disposal of voting rights | x | |||||||||||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||||||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||||||||||||||||
An event changing the breakdown of voting rights |
| |||||||||||||||||
Other (please specify): |
|
| ||||||||||||||||
3. Full name of person(s) subject to thenotification obligation: | Coronation Asset Management (Pty) Ltd | |||||||||||||||||
4. Full name of shareholder(s) (if different from 3.): | N/A | |||||||||||||||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 11 May 2017 | |||||||||||||||||
6. Date on which issuer notified: | 11 May 2017 | |||||||||||||||||
7. Threshold(s) that is/are crossed orreached:
| 5% | |||||||||||||||||
8. Notified details: |
| |||||||||||||||||
A: Voting rights attached to shares |
| |||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction |
| |||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights |
| |||||||||||||
Direct | Direct | Indirect | Direct | Indirect |
| |||||||||||||
GB00B8HX8Z88 | 37 306 089 | 37 306 089 | 36 139 844 | 36 139 844 |
| 4.90% |
|
| ||||||||||
|
| |||||||||||||||||
|
| |||||||||||||||||
B: Qualifying Financial Instruments |
| |||||||||||||||||
Resulting situation after the triggering transaction |
| |||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights |
| |||||||||||||
|
|
|
|
|
| |||||||||||||
|
| |||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
| |||||||||||||||||
Resulting situation after the triggering transaction |
| |||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
|
| ||||||||||||
|
|
|
|
| Nominal | Delta |
| |||||||||||
|
|
| ||||||||||||||||
|
| |||||||||||||||||
Total (A+B+C) |
| |||||||||||||||||
Number of voting rights | Percentage of voting rights |
| ||||||||||||||||
36 139 844 | 4.90% |
| ||||||||||||||||
|
|
| ||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: |
| |||||||||||||||||
|
| |||||||||||||||||
|
| |||||||||||||||||
Proxy Voting: |
| |||||||||||||||||
10. Name of the proxy holder: | Coronation Asset Management (Pty) Ltd |
| ||||||||||||||||
11. Number of voting rights proxy holder will ceaseto hold: |
|
| ||||||||||||||||
12. Date on which proxy holder will cease to holdvoting rights: |
|
| ||||||||||||||||
|
| |||||||||||||||||
13. Additional information: |
|
| ||||||||||||||||
14. Contact name: | Jamie Rowland |
| ||||||||||||||||
15. Contact telephone number: | +27 21 680 2000 |
| ||||||||||||||||
Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South
Africa and on the NSX in Namibia.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Related Shares:
MDC.L